Andrew Phillips Selected Research

Protease Inhibitors (Protease Inhibitor)

10/2019	Use of Contemporary Protease Inhibitors and Risk of Incident Chronic Kidney Disease in Persons With Human Immunodeficiency Virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study.
1/2018	Cardiovascular disease and use of contemporary protease inhibitors: the D:A:D international prospective multicohort study.
1/2016	Is nelfinavir exposure associated with cancer incidence in HIV-positive individuals?
1/2008	Population trends in the prevalence and patterns of protease resistance related to exposure to unboosted and boosted protease inhibitors.
4/2007	Class of antiretroviral drugs and the risk of myocardial infarction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrew Phillips Research Topics

Disease

31	Acquired Immunodeficiency Syndrome (AIDS) 11/2021 - 02/2005
12	Ovarian Neoplasms (Ovarian Cancer) 11/2023 - 01/2017
11	Neoplasms (Cancer) 11/2023 - 06/2010
9	Infections 01/2022 - 09/2005
7	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 10/2010
6	HIV Infections (HIV Infection) 01/2019 - 01/2008
6	Disease Progression 01/2014 - 04/2005
5	Myocardial Infarction 01/2018 - 04/2007
4	COVID-19 02/2024 - 01/2022
4	HIV Seropositivity 01/2015 - 01/2008
3	Chronic Renal Insufficiency 04/2024 - 11/2017
3	Coinfection 01/2014 - 03/2007
2	Wounds and Injuries (Trauma) 01/2022 - 07/2017
2	Insulin Resistance 11/2021 - 06/2008
2	Stroke (Strokes) 08/2019 - 01/2018
2	Viremia 02/2017 - 01/2013
2	Inflammation (Inflammations) 01/2017 - 01/2016
2	Persistent Infection 10/2014 - 02/2008
2	Hepatitis B 03/2013 - 03/2007
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2024
1	Atrial Flutter (Flutter, Atrial) 12/2022
1	Tachycardia (Tachyarrhythmias) 12/2022
1	Endometrial Neoplasms (Endometrial Cancer) 10/2022
1	Peritoneal Neoplasms 04/2022
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 03/2022
1	Open Fractures (Compound Fracture) 01/2022
1	Pharyngitis (Sore Throat) 01/2022
1	Pleural Effusion (Pleural Effusions) 01/2022
1	Hypertension (High Blood Pressure) 11/2021
1	Weight Gain 11/2021
1	Communicable Diseases (Infectious Diseases) 01/2020
1	Neural Tube Defects (Exencephaly) 01/2019
1	AIDS Dementia Complex 01/2018
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2018
1	Ovarian Epithelial Carcinoma 11/2017
1	Congenital Abnormalities (Deformity) 07/2017
1	Vascular System Injuries 01/2017
1	Kidney Diseases (Kidney Disease) 01/2017
1	Calculi (Calculus) 06/2016

Drug/Important Bio-Agent (IBA)

13	RNA (Ribonucleic Acid)IBA 11/2023 - 09/2005
9	Anti-HIV Agents (AIDS Drugs)IBA 10/2019 - 01/2010
5	Protease Inhibitors (Protease Inhibitor)IBA 10/2019 - 04/2007
5	Atazanavir Sulfate (Reyataz)FDA Link 01/2018 - 04/2015
5	efavirenz (Sustiva)FDA Link 01/2018 - 11/2011
4	Biomarkers (Surrogate Marker)IBA 10/2022 - 01/2016
4	Reverse Transcriptase InhibitorsIBA 01/2019 - 04/2007
4	Lopinavir FDA Link 01/2018 - 11/2011
4	LipidsIBA 01/2016 - 04/2007
3	PlatinumIBA 07/2020 - 01/2017
3	Ritonavir (Norvir)FDA Link 01/2018 - 01/2008
3	Darunavir (Prezista)FDA Link 01/2018 - 01/2017
3	Nevirapine (Viramune)FDA Link 01/2013 - 11/2009
2	Antihypertensive Agents (Antihypertensives)IBA 01/2024 - 01/2010
2	dolutegravirIBA 11/2021 - 01/2019
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 01/2020
2	Histocompatibility Antigens Class IIBA 01/2018 - 10/2011
2	NucleosidesIBA 01/2018 - 08/2012
2	fibrin fragment D (D-dimer)IBA 01/2017 - 01/2016
2	Interleukin-6 (Interleukin 6)IBA 01/2017 - 01/2016
2	Didanosine (Videx)FDA LinkGeneric 01/2016 - 11/2009
2	Stavudine (Zerit)FDA LinkGeneric 01/2016 - 11/2009
1	Antiviral Agents (Antivirals)IBA 02/2024
1	Anti-Arrhythmia AgentsIBA 12/2022
1	AntigensIBA 10/2022
1	Lactic Acid (Lactate)FDA LinkGeneric 04/2022
1	AlbuminsIBA 02/2022
1	Serum AlbuminIBA 02/2022
1	Clostridium perfringens epsilon-toxinIBA 02/2022
1	Monoclonal AntibodiesIBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	VaccinesIBA 01/2022
1	tenofovir alafenamideIBA 11/2021
1	Raltegravir Potassium FDA Link 11/2021
1	Pravastatin (Pravachol)FDA LinkGeneric 01/2021
1	pitavastatin (itavastatin)FDA Link 01/2021
1	Midazolam (Versed)FDA LinkGeneric 01/2020
1	BilirubinIBA 01/2018
1	ritonavir drug combination atazanavirIBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 06/2016
1	C-Reactive ProteinIBA 01/2016

Therapy/Procedure

26	Therapeutics 02/2024 - 02/2005
11	Highly Active Antiretroviral Therapy (HAART) 10/2014 - 02/2005
6	Art Therapy 04/2024 - 09/2012
4	Drug Therapy (Chemotherapy) 01/2023 - 01/2017
4	Cytoreduction Surgical Procedures 04/2022 - 11/2017
3	Adjuvant Chemotherapy 11/2023 - 11/2017
3	Neoadjuvant Therapy 02/2022 - 11/2017
2	Ambulatory Care (Outpatient Care) 01/2015 - 01/2013
1	Hysterectomy 10/2022
1	Lymph Node Excision (Lymph Node Dissection) 10/2022
1	Length of Stay 04/2022
1	Critical Care (Surgical Intensive Care) 04/2022
1	Gynecologic Surgical Procedures (Gynecologic Surgery) 03/2022
1	Splenectomy 01/2022
1	Negative-Pressure Wound Therapy 01/2022
1	Reoperation 01/2022
1	Male Circumcision 01/2019
1	Carotid Endarterectomy 01/2018
1	Prostheses and Implants (Prosthesis) 07/2017
1	Aftercare (After-Treatment) 02/2017